Patent AnalyticsExaminers
Rankings

Company or institution

Incyte Corporation

702 applicationsfiled 2007 to 2026

Allowance rate
77%
+2 pts vs the USPTO range 73% to 80%
Rejections before allowance
1.2
−0.4 vs the USPTO
Months to first action
12.8 mo
−5.8 vs the USPTO
Needed an RCE
19%
−8 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds373 apps
A61K Medical preparations224 apps
A61P Therapeutic activity of compounds59 apps
C07K Peptides27 apps
G01N Investigating or analysing materials6 apps
C12N Microorganisms or enzymes5 apps

Art units

1624174 apps
162592 apps
162681 apps
OPAP71 apps
162245 apps
162139 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19592326RUXOLITINIB FOR TREATING HIDRADENITIS SUPPURATIVA (HS)2026-06-01Pending00n/a
19673050TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS2026-05-11Pending102.3 mo
19584285ANTI-MUTANT CALRETICULIN (CALR) ANTIBODY-DRUG CONJUGATES AND USES THEREOF2026-05-01Pending00n/a
15222813Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15898696Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15584442Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15896848Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15747172Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15179617Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15642531Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 702 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in